UNC9975 - Moligand™ , Agonist of D 2 receptor, CAS No.U614664, Agonist of D 2 receptor

CAS: U614664 Cat. No.: U614664 PubChem CID: 56593482
Disponível para encomenda
GRAU & PUREZA Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools.
Storage
Room temperature
★
Tamanho
USA
Alemanha (EU)*
Preço
Qtd
5mg
U614664-5mg
Sob encomenda · 8–12 semanas
920,90US$
25mg
U614664-25mg
Sob encomenda · 8–12 semanas
1714,90US$
Enter a quantity for the sizes you want to add.

Especificações

Especificações e pureza
Moligand™
Condições de armazenamento de armazenamento
Room temperature
Grau
Moligand™
Tipo de ação
AGONIST
Mecanismo de ação
Agonist of D 2 receptor
Nomes e identificadores
SMILES
O=C1CCc2c(N1)nc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl
IUPAC Name
7-{4-[4-(2,3-dichlorophenyl)-1,4-diazepan-1-yl]butoxy}-1,2,3,4-tetrahydro-1,8-naphthyridin-2-one
InChIKey
JQSRFMXTGAVHIR-UHFFFAOYSA-N
InChI
1S/C23H28Cl2N4O2/c24-18-5-3-6-19(22(18)25)29-13-4-12-28(14-15-29)11-1-2-16-31-21-10-8-17-7-9-20(30)26-23(17)27-21/h3,5-6,8,10H,1-2,4,7,9,11-16H2,(H,26,27,30)
SMILES isoméricas
C1CN(CCN(C1)C2=C(C(=CC=C2)Cl)Cl)CCCCOC3=NC4=C(CCC(=O)N4)C=C3
PubChem CID
56593482

Dados avançados

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganoheterocyclic compounds
ClasseDiazanaphthalenes
SubclassNaphthyridines
Intermediate Tree Nodes Not available
Direct ParentNaphthyridines
Alternative Parents Aniline and substituted anilines  Dialkylarylamines  Dichlorobenzenes  1,4-diazepanes  Alkyl aryl ethers  Pyridines and derivatives  Aryl chlorides  Imidolactams  Heteroaromatic compounds  Lactams  Amino acids and derivatives  Secondary carboxylic acid amides  Trialkylamines  Azacyclic compounds  Hydrocarbon derivatives  Carbonyl compounds  Organic oxides  Organochlorides  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents Naphthyridine - Aniline or substituted anilines - Dialkylarylamine - 1,2-dichlorobenzene - 1,4-diazepane - Alkyl aryl ether - Chlorobenzene - Diazepane - Halobenzene - Aryl chloride - Aryl halide - Monocyclic benzene moiety - Imidolactam - Benzenoid - Pyridine - Heteroaromatic compound - Amino acid or derivatives - Carboxamide group - Tertiary aliphatic amine - Tertiary amine - Secondary carboxylic acid amide - Lactam - Carboxylic acid derivative - Azacycle - Ether - Organic nitrogen compound - Amine - Organic oxygen compound - Carbonyl group - Hydrocarbon derivative - Organooxygen compound - Organic oxide - Organonitrogen compound - Organohalogen compound - Organochloride - Aromatic heteropolycyclic compound
DescriçãoThis compound belongs to the class of organic compounds known as naphthyridines. These are compounds containing a naphthyridine moiety, a naphthalene in which a carbon atom has been replaced by a nitrogen in each of the two rings. The naphthyridine skeleton can also be described as an assembly two fused pyridine rings, which do not share their nitrogen atom.
External Descriptors Not available
Estrutura 3D
Modelo de Estrutura Química Interativa





Alvos associados (humanos)
DRD2 Tclin D(2) dopamine receptor (8 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
DRD3 Tclin D(3) dopamine receptor (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HTR2A Tclin 5-hydroxytryptamine receptor 2A (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HTR2C Tclin 5-hydroxytryptamine receptor 2C (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HTR1A Tclin 5-hydroxytryptamine receptor 1A (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HTR2B Tclin 5-hydroxytryptamine receptor 2B (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD1 Tclin Dopamine D1 receptor (9720 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD4 Tchem Dopamine D4 receptor (7907 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2A Tclin Serotonin 2a (5-HT2a) receptor (14758 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD5 Tchem Dopamine D5 receptor (1597 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mecanismos de ação
Certificados(CoA,COO,BSE/TSE e Mapa de Análise)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Calculadoras de soluções
Revisões

Avaliações dos Clientes

Application Protocols

No tested or validated application protocols are supplied for this item.

General starting points for screening compounds (not item‑specific):

  • DMSO master stock: prepare 10 mM; vortex and, if needed, sonicate briefly; verify concentration gravimetrically.
  • Biochemical assay dosing: generate 10‑point half‑log serial dilutions; maintain a constant final DMSO level (e.g., 0.5%). Include vehicle and positive controls.
  • Cell assays: begin with a broad range (e.g., 0.03–30 µM) and refine based on preliminary potency/toxicity; monitor for precipitation or color/fluorescence interference.
  • Analytical QC: run LC‑MS at time 0 and post‑assay to confirm chemical integrity; retain aliquots at each dilution step for retrospective analysis.

Please adapt to your SOPs and confirm compatibility with your assay system.

Biological Roles

Specific biological targets and pathways for UNC9975 are not provided in this listing.

General context for Moligand‑type tool compounds (not item‑specific):

  • May function as reversible ligands for enzymes, receptors, transporters, or protein–protein interaction surfaces in exploratory screening.
  • Utilized to probe pathway dependencies, validate targets, or establish structure–activity relationships (SAR) through analog comparison.
  • Employed in chemoproteomics or thermal shift profiling to map target engagement in cell lysates or live cells.

Best practices:

  • Use multiple orthogonal assays to confirm biological effects and exclude assay artifacts (aggregation, fluorescence interference, redox cycling, or covalent reactivity).
  • Establish concentration–response curves with appropriate vehicle controls and counter‑screens.
  • Confirm chemical stability and purity over the course of biological experiments to avoid misattribution of activity to impurities or degradants.

Note: No claims of therapeutic effect are made. This product is for research use only.

Buffer Applications

This product is not a buffering agent. Buffer formulation guidance is generally not applicable.

Practical notes for assay buffers (general, not item‑specific):

  • When dosing from DMSO stocks, pre‑warm buffers and add compound last with thorough mixing to minimize precipitation.
  • Maintain consistent final vehicle percentage across control and treated wells (commonly 0.1–1% DMSO).
  • For low‑solubility compounds, include permissible cosolvent (e.g., 1–5% ACN or EtOH) or a small amount of nonionic surfactant if validated for the assay.

For specific pH ranges and buffer systems, follow assay‑specific SOPs; no buffer capacity data exist for this item.

Green Alternatives

Although UNC9975 is not a solvent or bulk reagent, greener practices can be applied to its preparation, use, and disposal. The focus is on solvent choice, miniaturization, and waste minimization.

Greener handling strategies (general guidance):

  • Stock solvents: If compatible with solubility and assay, consider ethanol or aqueous cosolvent systems to reduce DMSO usage; validate stability and activity.
  • Miniaturization: Use low‑volume plates (384/1536‑well) and acoustic dispensing to reduce solvent and compound consumption.
  • Analytical methods: Favor LC‑MS with short gradients and water‑rich eluents; recycle solvent where validated. Use inline SPE to reduce organic volumes.
  • Waste reduction: Centralize compound dilutions and share ready‑to‑use plates across assays to avoid duplicate solutions and expired stocks.

Illustrative comparison (typical, not item‑specific):

  • DMSO vs EtOH for stock preparation:
    • DMSO: superior solvency; stable; typical default for hydrophobic molecules; higher environmental persistence.
    • EtOH: renewable, lower toxicity; may limit achievable concentration for lipophilic compounds; volatility can alter dosing if not controlled.

Trade‑offs:

  • Greener cosolvents may constrain solubility windows and complicate assay tolerability. Any substitution must be empirically verified for potency, stability, and background signal.
Pharmaceutical Uses

No excipient or pharmacopeial information is provided for UNC9975, and it is not offered for clinical or diagnostic applications.

General, non‑clinical context for screening compounds:

  • Tool compounds may be used in preclinical discovery research to interrogate targets, build SAR, or serve as internal standards and positive controls in analytical methods.
  • Not GMP qualified; no compendial monograph is indicated.

Item‑specific status:

  • Regulatory status: research use only.
  • Excipient/formulation role: Not specified for this item; refer to CoA/Spec Sheet if any ancillary information is later provided.

Any use in pharmaceutical manufacturing, clinical studies, or diagnostics is outside the scope of this product listing.

Physical Properties

Item-specific physical constants have not been provided in this listing. Do not treat the following as specifications; verify with the CoA/Spec Sheet.

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point (MP): Not specified for this item; refer to CoA/Spec Sheet.
  • Boiling point (BP): Not specified for this item; refer to CoA/Spec Sheet.
  • Density: Not specified for this item; refer to CoA/Spec Sheet.
  • Refractive index: Not applicable unless a liquid; Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility: Not specified for this item; refer to CoA/Spec Sheet. General practice for screening ligands is initial dissolution in anhydrous DMSO to 10–50 mM, then dilution into assay buffer with appropriate cosolvent.
  • pKa/logP/logD: Not specified for this item; refer to CoA/Spec Sheet.

General laboratory guidance (literature/practice-based, not item-specific):

  • Many drug‑like small molecules show good solubility in DMSO and variable solubility in aqueous buffers; pre-screen solubility across DMSO, DMF, MeOH, ACN, and buffered aqueous mixtures.
  • If polymorphism is possible, thermal methods (DSC) and PXRD can clarify solid‑state form prior to use in quantitative assays.
  • For spectroscopic quantitation, an extinction coefficient is required; in its absence, use gravimetric/DMSO stock preparation and validated dilutions.
Quality and Grades
  • Grade/Purity: Moligand™ (as provided). Moligand™ denotes a screening‑grade small molecule suitable for ligand discovery, target engagement, and SAR exploration. It is intended for in‑vitro/in‑cell research use and method development rather than for clinical or diagnostic use.
  • Typical documentation: Identity, purity, and analytical details are normally confirmed by CoA/Spec Sheet; item‑specific acceptance criteria are not listed here.

What Moligand™ generally implies (general guidance; not a specification for this item):

  • Emphasis on suitability for biochemical/cellular assays and library screening.
  • Supplied for use as a research tool compound or reference material in assay development.
  • May be amenable to plate formatting and DMSO stock preparation; confirm any salt form and residual solvent levels on the CoA.

This item’s specifics:

  • Purity level, chromatographic profile, water/peroxide/metal content, residual solvents, and salt/form: Not specified for this item; refer to CoA/Spec Sheet.
  • Stabilizers/additives: Not specified for this item; refer to CoA/Spec Sheet.

Recommendations:

  • Verify identity and purity by LC‑MS/NMR upon receipt if study demands are stringent (e.g., quantitative pharmacology, chemoproteomics).
  • For quantitative work, determine exact concentration of DMSO stocks by gravimetry and, if feasible, qNMR or UV with known extinction coefficients.
Reaction and Applications

This product is offered as a research screening ligand (Moligand™) rather than a general synthetic reagent. Accordingly, its primary applications are in chemical biology and discovery workflows rather than as a stoichiometric building block.

Typical uses (general for screening compounds):

  • Target engagement studies: establish binding to proteins using biochemical assays (e.g., enzymatic inhibition/activation, TR‑FRET, AlphaScreen) or biophysical methods (SPR, MST, DSF).
  • Cell‑based assays: evaluate phenotypic responses, pathway modulation, or reporter readouts; titrate across multiple concentrations to derive potency metrics.
  • Reference/control: serve as a positive/negative control or standard in assay development and HTS triage.
  • Analytical standard: retention time marker and method‑development test article for LC‑UV/LC‑MS.

Practical considerations:

  • Prepare concentrated DMSO stocks and aliquot to minimize freeze–thaw and moisture uptake.
  • Assess compound stability under assay conditions (light, oxygen, pH); perform time‑course stability checks by LC‑MS.
  • If mechanism studies are intended, orthogonal readouts are recommended to control for aggregation, fluorescence interference, or redox cycling.

Note: No manufacturer‑supplied application notes are provided for this item; the above are general practices for Moligand‑type tool compounds.

Reaction Conditions

This item is not primarily intended for use as a synthetic reagent, and no item‑specific reactivity or conditions are provided.

General laboratory conditions for handling screening compounds (not item‑specific):

  • Stock preparation: 10–50 mM in dry DMSO; filter (0.2 µm PTFE) if particulates are present; aliquot and store protected from moisture and light.
  • Assay dosing: dilute into buffer to desired concentrations keeping vehicle constant; mix gently to avoid foaming and precipitation.
  • Stability checks: incubate at assay temperature (e.g., 25–37°C) and analyze by LC‑MS over the assay time course to confirm integrity.

If UNC9975 is to be used in chemical reactions or conjugations, establish conditions only after structure is verified and small‑scale tests confirm compatibility.

Safety and Handling

Hazard classification is not provided for this item. Handle as a laboratory chemical of unknown toxicity and follow institutional best practices. Always consult the SDS when it becomes available for authoritative guidance.

  • GHS classification, signal word, pictograms, H‑statements: Not specified for this item; refer to SDS.
  • Primary risks (general for research small molecules): potential skin/eye irritation; harmful if swallowed or inhaled; unknown chronic toxicity.
  • PPE: lab coat, safety glasses, and suitable chemical-resistant gloves (e.g., nitrile). Work in a fume hood to minimize inhalation exposure.
  • Handling: avoid dust/aerosol generation; keep containers tightly closed; use clean, dry tools to prevent contamination.
  • Incompatibilities: without structure-specific data, avoid strong oxidizers/reductants and reactive bases/acids until compatibility is established.
  • First aid (general):
    • Inhalation: move to fresh air; seek medical attention if symptoms persist.
    • Skin/eye contact: rinse with water for at least 15 minutes; remove contaminated clothing; seek medical advice for persistent irritation.
    • Ingestion: rinse mouth; do not induce vomiting; seek medical attention.
  • Spill response: avoid dust formation; collect mechanically or with inert absorbent; dispose according to local regulations.
  • Waste: treat as organic laboratory chemical waste; segregate halogenated vs non‑halogenated solvents used during workup.

Note: This product is for research use only.

Solvent Selection

Because structural details and solubility data are not provided, begin with broadly compatible organic solvents commonly used for screening compounds. Guidance below is general and should be validated experimentally for UNC9975.

  • Primary solvent for stocks: DMSO (anhydrous) is the default for 10–50 mM master stocks due to high solvating power and assay compatibility at low final %.
  • Secondary solvents: DMF, ethanol, methanol, and acetonitrile can assist in co‑solvent systems or analytical sample prep (HPLC/LC‑MS).
  • Aqueous systems: Dilute DMSO stocks into buffer with gentle mixing; maintain final DMSO ≤0.1–1% v/v for sensitive biochemical assays, or ≤0.5–2% for many cell assays (assay‑dependent).
  • Cosolvent strategies: Use 5–20% ACN or MeOH in buffer for HPLC injections; add nonionic surfactants (e.g., 0.01–0.1% Tween‑20) cautiously if precipitation is problematic in biological buffers.
  • Drying/degassing: For moisture‑sensitive assays or analytical stability, use anhydrous solvents and inert atmosphere handling until stability is confirmed.

Quick comparison (general, not item-specific):

  • DMSO: strongest solvency; high bp; miscible with water; may affect some enzymes at >1%.
  • DMF: strong polar aprotic; more toxic; good for challenging solids; less favored in bioassays.
  • EtOH/MeOH: volatile, assay‑tolerated at low %; limited solvency for highly lipophilic compounds.
  • ACN: excellent for LC‑MS; moderate solvency; volatile and low viscosity.
Storage and Reconstitution
  • Storage conditions (as provided): Room temperature.
  • Shipped in: Not specified for this item; refer to CoA/Spec Sheet.
  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.

Reconstitution (general guidance for screening compounds; verify with your lab SOPs):

  • Solvent: Use anhydrous DMSO for initial stocks unless the CoA indicates a preferred solvent or salt form. Typical stock concentration 10–50 mM.
  • Technique: Allow vial to equilibrate to room temperature before opening to avoid moisture condensation. Weigh quickly, cap promptly. If needed, sonicate briefly to aid dissolution. Filter through 0.2 µm PTFE if particles persist.
  • Aliquoting: Dispense single‑use aliquots in inert vials or low‑bind plates to avoid repeated freeze–thaw and adsorption losses.
  • Light/moisture protection: Store stocks in amber, tightly sealed containers with desiccant. Purge headspace with inert gas if compound is oxygen‑sensitive (unknown for this item).
  • Working solutions: Prepare fresh on the day of use when possible; document final vehicle percentage in assays.

Stability/shelf life: Not specified for this item; refer to CoA/Spec Sheet. If no data are available, periodically re‑assess by LC‑MS/LC‑UV to confirm integrity during storage.

Note: For research use only.

Structure and Identity

This product is a small‑molecule screening ligand from the Moligand series; detailed structural identifiers are not fully specified in the current listing.

  • Product name: UNC9975 (SKU: U614664)
  • CAS: U614664 (catalog placeholder; Not specified for this item; refer to CoA/Spec Sheet.)
  • CID: 56593482 (external registry identifier; structural details not confirmed here)
  • InChIKey: 167558 (as provided; format appears abbreviated)
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.

Structural features (general guidance):

  • Without a confirmed structure, functional groups, ring systems, and stereochemistry cannot be asserted for this specific item.
  • As a Moligand screening compound, UNC9975 is expected to be an organic small molecule suitable for target engagement studies; confirm exact features via the CoA/SDS or primary reference.

2D structure description (general):

  • Not available for this listing. Please consult the Certificate of Analysis (CoA) or structure file (SDF/SMILES) when provided for precise atom connectivity and functional‑group annotation.
Synthetic Utility

UNC9975 is provided as a screening ligand rather than a general synthetic building block. Without structural disclosure, synthetic transformations cannot be specified.

General considerations for small‑molecule tool compounds (not item‑specific):

  • If derivatization is intended (e.g., for probe development, biotinylation, fluorophore conjugation), first confirm the presence and accessibility of functional handles (amines, alcohols, carboxylates, halides) from the structural data/CoA.
  • Stable isotopologue or photoaffinity variants may be prepared for mechanistic studies; plan synthetic routes accordingly once structure is confirmed.
  • For analytical support, impurity reference standards or degradation products can be synthesized to aid method qualification.

Recommendation:

  • Obtain full structural information (SMILES/SDF) and confirm salt form and stereochemistry before planning any synthetic modification.
Target Specificity

No target, selectivity profile, or binding data are provided for UNC9975 in this listing.

  • Target(s): Not specified for this item; refer to CoA/Spec Sheet or primary literature.
  • Species cross‑reactivity: Not applicable.
  • Mechanism of action: Not specified for this item.

Guidance (general, not item‑specific):

  • Establish target specificity using orthogonal methods (biochemical potency, biophysical binding, cellular phenotypes, genetic rescue/knockdown).
  • Include selectivity panels against related protein families to quantify off‑target interactions where relevant.

Perguntas frequentes

What is Moligand??
Moligand? is one of Aladdin Scientific's premium product lines, formulated for high-purity applications across multiple workflows. Compared to standard grades in the same workflow, Moligand? products typically offer tighter specifications, more rigorous QC, and stronger lot-to-lot consistency.
How should this product be stored?
Store at room temperature.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is U614664. InChIKey JQSRFMXTGAVHIR-UHFFFAOYSA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Precisa de ajuda para escolher o grau?

O nosso guia de seleção de graus abrange pureza, estado do estabilizador e adequação à aplicação para todas as variantes do nosso catálogo.

Ver o guia de graus Moligand™ →

Deseja que lhe enviemos uma mensagem quando tivermos descontos disponíveis?

Lembrar-me mais tarde

Obrigado! Por favor, verifique a sua caixa de entrada de e-mail para confirmar.

Ops! As notificações estão desativadas.